Page last updated: 2024-10-30

mephenytoin and Anemia, Hemolytic

mephenytoin has been researched along with Anemia, Hemolytic in 1 studies

Mephenytoin: An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.
mephenytoin : An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SNAPPER, I1
MARKS, D1
SCHWARTZ, L1
HOLLANDER, L1

Other Studies

1 other study available for mephenytoin and Anemia, Hemolytic

ArticleYear
Hemolytic anemia secondary to mesantoin.
    Annals of internal medicine, 1953, Volume: 39, Issue:3

    Topics: Anemia; Anemia, Hemolytic; Humans; Hydantoins; Mephenytoin

1953